Literature DB >> 742911

In vitro thymosin- and levamisole-induced increase of lymphocyte transformation in psoriatic patients.

J Eskola, E Soppi, O Ruuskanen, J E Fräki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 742911     DOI: 10.1007/bf00446950

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  15 in total

1.  The effect of levamisole on cell-mediated immunity and suppressor cell function.

Authors:  D Sampson; A Lui
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

2.  Levamisol in psoriatic arthritis.

Authors:  M Rosenthal; U Trabert
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

3.  Immunosuppression after cholecystectomy.

Authors:  M Salo; J Eskola
Journal:  Acta Anaesthesiol Scand       Date:  1977       Impact factor: 2.105

4.  Effect of levamisole on the maturation of guinea pig thymocytes.

Authors:  E Soppi; J Fräki; J Eskola; O Ruuskanen
Journal:  Clin Immunol Immunopathol       Date:  1978-11

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium.

Authors:  S Horowitz; W Borcherding; A V Moorthy; R Chesney; H Schulte-Wisserman; R Hong
Journal:  Science       Date:  1977-09-02       Impact factor: 47.728

7.  Effect of 8-methoxypsoralen plus UVA (PUVA) on lymphocyte transformation and T cells in psoriatic patients.

Authors:  J E Fräki; J Eskola; V K Hopsu-Havu
Journal:  Br J Dermatol       Date:  1979-05       Impact factor: 9.302

8.  [Immunogenetic aspects of the pathogenesis of psoriasis].

Authors:  R H Cormane; J Hunyadi; F Hamerlinck
Journal:  Dermatol Monatsschr       Date:  1977-11

9.  Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months.

Authors:  B L Gordon; R Yanagihara
Journal:  Ann Allergy       Date:  1977-10

10.  The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.

Authors:  R Michalevicz; A Many; B Ramot; N Trainin
Journal:  Clin Exp Immunol       Date:  1978-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.